Physician profile
Binod Bista
NPI 1073769493
$1,535.22
in general payments reported to CMS, 2019-2025
19 companies · $256 in 2025
The $256 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $276 · 2021: $250 · 2022: $138 · 2023: $59.19 · 2024: $417 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $642 · Debt Forgiveness: $89.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $642.34 |
| Debt Forgiveness | $89.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $241.10 | 2019-2025 | Vaxneuvance, Gardasil 9, Capvaxive |
| Pfizer INC. | $198.84 | 2019-2025 | |
| Alk-Abello, INC | $153.96 | 2024-2025 | Odactra, Grastek, Ragwitek |
| Astrazeneca Pharmaceuticals LP | $130.43 | 2019-2024 | Farxiga |
| Novo Nordisk INC | $129.20 | 2019-2025 | Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $122.34 | 2020-2025 | Xifaxan |
| Baxter Healthcare | $89.94 | 2024 | |
| Abbott Laboratories | $76.54 | 2021-2024 | Freestyle Libre 2 |
| Corium, LLC | $71.66 | 2022-2024 | Azstarys |
| Glaxosmithkline, LLC. | $71.47 | 2019-2020 | |
| Sanofi Pasteur INC. | $62.24 | 2021-2025 | |
| Eisai INC. | $40.89 | 2020-2021 | |
| Lilly USA, LLC | $32.31 | 2022-2024 | Mounjaro |
| Dexcom, INC. | $21.59 | 2024 | Dexcom G6 Transmitter |
| Abbvie INC. | $21.36 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $18.88 | 2025 | Voquezna |
| Exact Sciences Corporation | $18.35 | 2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $17.14 | 2022 | |
| Amgen INC. | $16.98 | 2025 | Repatha, Otezla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Binod Bista listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.